Publication | Closed Access

Efficacy and Feasibility of Sorafenib as a Maintenance Agent After Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Mutated Acute Myeloid Leukemia: An Update

Hematological MalignancyMaintenance AgentCell TherapyTransplantationMarrow TransplantationMedicineStem Cell TransplantationHematologyImmunologyCell BiologyRadiation OncologyStem CellsCell TransplantationHealth Sciences